Pulse Biosciences (PLSE) 10-Q2023 Q1 Quarterly report

Filed: 11 May 23, 4:20pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Abbott, acellular, arbitration, AtriCure, bank, banking, Biosense, blood, booked, Boston, cardiothoracic, cartilage, cellular, char, circular, circumferential, clamp, cold, collagen, cryoablation, cure, customary, deeper, defense, departure, disagreement, Dunnington, ear, electrode, electrophysiology, endoluminal, endoscopic, fulltime, Gan, gastroenterology, gynecology, heat, Helena, invasive, issuer, Johnson, low, maker, Medtronic, microsecond, millisecond, muscle, Napa, noncellular, nose, nsPFA, open, parallel, permanent, PFA, phase, plc, profile, profoundly, pulmonary, resolution, revolutionary, scraped, shown, Silicon, St, surgeon, surgery, thicker, throat, today, uniquely, Valley, Webster

Removed: accessed, accomplish, Accountability, accustomed, add, addressed, adjust, afford, age, AI, allege, assertion, assisting, attack, Attorney, bore, brand, broadening, build, building, cancel, CCPA, cell, chain, Children, clinic, collectively, comparative, comparing, complicating, conceal, concealing, constantly, consumer, contradictory, convert, conviction, cosmetic, CPRA, criticized, cumulative, curtailment, death, declared, deductible, deducting, defining, defraud, denied, discovery, dissemination, distinctive, economically, educating, enforcing, entrance, epidemic, equaled, equipped, ESG, evidence, exclusion, exclusivity, executed, executing, expecting, expiration, expired, failing, falsifying, financed, flat, flux, focused, generating, handle, heavily, HIPAA, HITECH, holder, hyperplasia, implementing, imprisonment, improbable, incident, induce, infrastructure, infringed, initiative, injunctive, inspect, insurer, integration, interchangeable, internationally, interpretation, interpreted, IPO, jeopardized, kind, knowingly, landscape, laser, lawsuit, left, leverage, maintained, malfeasance, mandatory, mitigation, modify, motion, move, negotiation, Northern, onboarded, oppose, Opposition, opt, opted, overhead, owner, pattern, penalty, pending, Portability, portfolio, preempted, presenting, President, preventative, primary, prioritization, privacy, processing, proving, quantity, questioned, qui, recommendation, redeemed, referral, reimbursed, rejection, relief, remediate, remote, remotely, remuneration, request, responsibility, resulted, reward, safeguarding, scheme, settled, seventy, signaling, situation, social, soliciting, sponsoring, statute, stolen, submission, subsided, substantive, Sunshine, survive, tam, teaching, therapeutic, threat, touch, trademark, transmission, travel, Treasurer, unbilled, uncapitalized, uncertainty, uncollectible, understand, unexercised, unfair, unmet, unspecified, USPTO, valuable, vary, vested, Vice, voluntary, whistleblower, willfully, workflow, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PLSE transcripts

PLSE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Pulse Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 11, 2023		/s/ Kevin P. Danahy
		Kevin P. Danahy
		Chief Executive Officer
		(Principal Executive and Principal Financial Officer)

This certification is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Pulse Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any general incorporation language contained in such filing.